IL17C and chronic obstructive pulmonary disease: Specifically, pathogenic bacteria, such as influenza, increases epithelial IL-17C production in chronic obstructive pulmonary disease (COPD) patients, thus enhancing tumor growth through neutrophilic inflammation in the tumor microenvironment [51].